First Time Loading...

Pfizer Inc

Watchlist Manager
Pfizer Inc Logo
Pfizer Inc
Price: 33.1 USD +3.15% Market Closed
Updated: Sep 30, 2023

Intrinsic Value

Intrinsic Value History
Pfizer Inc

Whether you're assessing long-term stability or short-term opportunities, Historical Valuation serves as a vital tool to enhance your investment approach, enabling you to make more informed investment decisions.

This feature available only with
Unlimited Plan

Sign up to access Pfizer Inc's intrinsic value history.

No restrictions, no limits.
All stocks, all tools.

Spot Contrarian Opportunities

Look for stocks that have been historically overvalued but are now trading below their intrinsic value.

Easily Identify Value Traps

Avoid stocks that are always undervalued and never reach their intrinsic value.

Find Strong Rebounds

Find stocks that have historically corrected quickly from being undervalued to reaching their intrinsic value.

Valuation Methods

There are two methods to calculate the Intrinsic Value of a stock: DCF Valuation and Relative Valuation. We take the average of these two methods to estimate the intrinsic value as accurately as possible. You can see the Intrinsic Value of a stock at the top of this page.

DCF Value
Discounted Cash Flow

DCF Parameters:
Operating Model
Discount Rate
Forecast Period
Terminal Growth
DCF Input
DCF Input
DCF Input

Fundamental Analysis


Balance Sheet Decomposition
Pfizer Inc

Current Assets 50.1B
Cash & Short-Term Investments 20B
Receivables 15.4B
Other Current Assets 14.7B
Non-Current Assets 146B
Long-Term Investments 14.7B
PP&E 17.1B
Intangibles 93.5B
Other Non-Current Assets 20.3B
Current Liabilities 36.6B
Accounts Payable 6.1B
Accrued Liabilities 2.3B
Short-Term Debt 621m
Other Current Liabilities 27.5B
Non-Current Liabilities 58.1B
Long-Term Debt 31.7B
Other Non-Current Liabilities 26.4B
Fundamental Scores

PFE Profitability Score
Profitability Due Diligence

Pfizer Inc's profitability score is 71/100. The higher the profitability score, the more profitable the company is.

Positive Free Cash Flow
Positive Gross Profit
Exceptional 3-Year Average ROE
Positive Operating Income

Pfizer Inc's profitability score is 71/100. The higher the profitability score, the more profitable the company is.

PFE Solvency Score
Solvency Due Diligence

Pfizer Inc's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Low D/E
High Altman Z-Score
Long-Term Solvency

Pfizer Inc's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PFE Price Targets Summary
Pfizer Inc

Wall Street analysts forecast PFE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PFE is 44.97 USD with a low forecast of 32.32 USD and a high forecast of 78.75 USD.

Price Target
32.32 USD
2% Downside
Price Target
44.97 USD
36% Upside
Price Target
78.75 USD
138% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape


PFE Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

PFE Return Decomposition
Main factors of price return

What is price return decomposition?

PFE Price
Pfizer Inc

1M 1M
6M 6M
1Y 1Y
3Y 3Y
5Y 5Y
10Y 10Y
Annual Price Range
52w Low
52w High
Price Metrics
Average Annual Return 13.9%
Standard Deviation of Annual Returns 30.94%
Max Drawdown -45%
Shares Statistics
Market Capitalization 187B USD
Shares Outstanding 5 727 000 000
Percentage of Shares Shorted 0.89%

PFE News

Last Video News
Pfizer Inc

Other Videos

Last Important Events
Pfizer Inc

Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.


Sentiment Analysis
Pfizer Inc

Last 7 Days
Last 30 Days
Last 90 Days

Company Profile

Pfizer Inc Logo
Pfizer Inc


United States of America



Market Cap

187B USD

Dividend Yield



Pfizer Inc. is a research-based global biopharmaceutical company. The company is headquartered in New York City, New York and currently employs 79,000 full-time employees. The firm is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The firm offers therapeutic candidates in gastroenterology, dermatology, and cardiology, including etrasimod, an oral, selective sphingosine 1-phosphate (S1P) receptor modulator in development for a range of immuno-inflammatory diseases, including ulcerative colitis, Crohn’s Disease, atopic dermatitis, eosinophilic esophagitis, and alopecia areata. The firm works across markets to develop wellness, prevention, treatments and cures. The company collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. The firm's medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness.


New York City
235 E 42nd St




79 000


Chairman & CEO
Dr. Albert Bourla D.V.M., DVM, Ph.D.
CFO & Exec. VP
Mr. Frank A. D'Amelio
Chief Scientific Officer and Pres of Worldwide Research, Devel. & Medical
Dr. Mikael Dolsten M.D., Ph.D.
Exec. VP & Gen. Counsel
Mr. Douglas M. Lankler
Mr. John D. Young
Chief Commercial Officer & Pres of Global Biopharmaceuticals Bus.
Ms. Angela Hwang
Show More
Chief Financial Officer & Exec. VP
Mr. David M. Denton
Sr. VP, Controller & Principal Accounting Officer
Ms. Jennifer B. Damico
Exec. VP and Chief Digital & Technology Officer
Ms. Lidia L. Fonseca
Sr. VP & Chief Investor Relations Officer
Mr. Christopher J. Stevo CFA
Show Less

See Also

Other Stocks
What is the Intrinsic Value of one PFE stock?

The intrinsic value of one PFE stock under the Base Case scenario is 42.49 USD.

Is PFE stock undervalued or overvalued?

Compared to the current market price of 33.1 USD, Pfizer Inc is Undervalued by 22%.